ID: ALA280688

Max Phase: Preclinical

Molecular Formula: C21H31NO

Molecular Weight: 313.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCC23CCCCC2C1Cc1ccc(OC(C)(C)C)cc13

Standard InChI:  InChI=1S/C21H31NO/c1-20(2,3)23-16-9-8-15-13-19-17-7-5-6-10-21(17,18(15)14-16)11-12-22(19)4/h8-9,14,17,19H,5-7,10-13H2,1-4H3

Standard InChI Key:  HWTLPRHSBYNYIX-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Opioid receptor 338 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 313.49Molecular Weight (Monoisotopic): 313.2406AlogP: 4.55#Rotatable Bonds: 1
Polar Surface Area: 12.47Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.84CX LogP: 4.55CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: 0.91

References

1. Mohacsi E, Leimgruber W, Baruth H..  (1982)  Synthesis and pharmacology of metabolically stable tert-butyl ethers of morphine and levorphanol.,  25  (10): [PMID:6292420] [10.1021/jm00352a037]

Source